Ache — LLMpedia

Ache
Name	Ache
Synonyms	Pain, discomfort, soreness
Field	World Health Organization; National Institutes of Health
Symptoms	Localized or diffuse discomfort, tenderness, stiffness
Complications	Reduced mobility, sleep disturbance, depression
Onset	Acute or chronic
Duration	Transient to persistent
Treatment	Analgesics, physical therapy, psychotherapy, interventional procedures

Contents

Ache

Ache refers to subjective bodily discomfort ranging from mild soreness to intense pain. Historically discussed in texts by Hippocrates, debated in treatises of Avicenna and empirically investigated by researchers at institutions such as Mayo Clinic, Johns Hopkins Hospital, and Karolinska Institutet. Modern clinical frameworks from bodies like the World Health Organization and National Institutes of Health situate ache within diagnostic systems used by specialists at centers including Cleveland Clinic and Massachusetts General Hospital.

Definition and Classification

Clinical definitions derive from consensus statements by organizations such as International Association for the Study of Pain and diagnostic criteria in manuals like the Diagnostic and Statistical Manual of Mental Disorders and the International Classification of Diseases. Classification schemes often follow schemes developed at Royal College of Physicians and research groups at Stanford University School of Medicine. Subtyping distinguishes nociceptive processes described in research at University College London from neuropathic syndromes characterized in publications from Karolinska Institutet and central sensitization concepts framed by investigators at McGill University.

Etiological models rely on work from laboratories at Harvard Medical School and University of Oxford integrating findings on peripheral nociceptors studied at Salk Institute with central processing mapped in studies at Max Planck Institute for Human Cognitive and Brain Sciences. Mechanistic pathways incorporate inflammation pathways elucidated by researchers at Broad Institute and immune-neural interactions characterized in studies from Rockefeller University. Neurotransmitter systems implicated include findings on substance P and glutamate from teams at Cold Spring Harbor Laboratory and endogenous opioid pathways described in investigations at Princeton University. Genetic predispositions have been explored in genome-wide association studies led by groups at Wellcome Sanger Institute and Broad Institute.

Clinically recognised categories align with taxonomies produced by the International Association for the Study of Pain and specialty societies such as the American Academy of Neurology. Examples include musculoskeletal pain syndromes characterized in cohorts at Mayo Clinic and Hospital for Special Surgery, neuropathic pain profiles as described in studies at Johns Hopkins University School of Medicine, visceral pain entities investigated at Cleveland Clinic and craniofacial pain patterns documented by teams at Tufts University School of Dental Medicine. Referred pain phenomena have been detailed in surgical literature from Royal College of Surgeons of England, while systemic pain syndromes such as fibromyalgia are subjects of clinical trials at National Institutes of Health and longitudinal studies at King's College London.

Assessment protocols reflect guidelines from National Institute for Health and Care Excellence and diagnostic pathways used in clinics at Mayo Clinic and academic centers like Columbia University Irving Medical Center. Structured interviews and pain scales trace lineage to measurement tools developed at McMaster University and psychometric work from University of Cambridge. Imaging modalities employed include protocols from Massachusetts General Hospital radiology and functional neuroimaging paradigms refined at University of California, Los Angeles and Stanford University. Electrophysiological techniques are used in laboratories at University of Pennsylvania and diagnostic algorithms appear in position statements from American Pain Society.

Therapeutic approaches span pharmacological regimens informed by trials at National Institutes of Health and device-based interventions validated in multicenter studies involving Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital. Pharmacotherapies draw on evidence regarding nonsteroidal agents studied at Oxford University and opioid stewardship informed by guidelines from Centers for Disease Control and Prevention. Nonpharmacologic modalities include physical rehabilitation protocols standardized by American Physical Therapy Association and cognitive-behavioral interventions developed at University of Massachusetts Medical School and University of Michigan. Interventional procedures are performed in centers such as UCLA Health and outcomes reported by teams at Mount Sinai Health System. Complementary strategies appear in trials from National Center for Complementary and Integrative Health.

Population-level analyses derive from surveillance by World Health Organization and national data sets curated by agencies like Centers for Disease Control and Prevention and Office for National Statistics. Large cohort studies from Framingham Heart Study and consortiums coordinated through European Pain Federation document prevalence and burden. Economic impact assessments cite healthcare utilization reports from Organisation for Economic Co-operation and Development and health services research at Harvard T.H. Chan School of Public Health. Comorbidity patterns have been reported in registries maintained by Veterans Health Administration and multi-institutional collaborations involving Johns Hopkins University and University of Toronto.

Category:Pain